Many thanks to eyeforpharma Philadelphia for the opportunity to discuss the importance of moving disease care to health care; here’s to a future hashtag#worldwithoutdisease http://bit.ly/efpPHL hashtag#efpphilly hashtag#healthinnovation
As we enter election year in 2020, the pressure has never been higher on our industry to justify what we add to the cost of healthcare. Price control has become a bipartisan issue and across the wide-range of policy positions that are on the table in Fall 2020, one area is clear: the transition towards value-based care is inevitable.
Compared to last decade, when we were rightly taken to task for bloated pipelines with costly ‘me-too’ treatments, the situation couldn’t be more different. We are on the verge of a new golden age for R&D. Personalized care is starting to deliver. Innovations in cell gene, Car-T and curative therapies offer transformative impact to patients. The problem is: they are also very expensive.
Let’s get ahead of this crisis and come together to define a better way forward.
David Loew, EVP, Head, Sanofi PasteurPharma can become a solution for sustainable healthcare, and eyeforpharma is where our leaders combine with healthcare innovators to move us forward.
Ramona Sequeira President Takeda U.S.A
Sebastian Guth President, Americas Bayer
Ivan Cheung CEO & President Eisai Inc.
Jeff Marrazzo CEO Spark Therapeutics
Anne Heatherington SVP, Head of Data Sciences Institute Takeda
Rob Scott Chief Medical Officer Abbvie
Chris Leibman SVP, Value and Access Biogen
Jackie Hunter CE Clinical and Strategic Partnerships Benevolent AI
Ester Banque SVP & Head Intercontinental Commercial Bristol-Myers Squibb
Robert W. Dubois CSO & EVP National Pharmaceutical Council
Sarah Emond EVP and COO ICER
Scott Howell VP and Head, US Market Access, Pharmaceuticals Novartis
Join forces with providers: Strategic engagements are bringing results. Scale creative partnerships with providers and join our IDN Panel to hear what your customer really wants.
Sustain breakthrough innovations: Industry heavyweights join MIT NEWDIGS, ICER, NPC, TransCelerate, the FDA and patient groups to present a roadmap of how we ensure access.
The future is here: Our new Innovation Stage showcases breakthroughs in AI, immersive media and blockchain. Our Digital & Marketing Stage provides practical tools to implement.
The patient comes first: Collaborate with your most important stakeholder, see how patient entrepreneurs are turning bad into good, and implement patient-first transformation.
Commercial & Sales Connect to customers through intelligent engagement and empathetic partnerships
RWE & Data Science Let's optimize and accelerate our industry with a vision that powers strategy with evidence and insights
Patient Engagement Destroy tokenism by providing meaningful and measurable value to patients
The Innovation Stage Get yourself out of your comfort zone to explore the new frontiers of medicine, from the digitome to advanced genomics via blockchain, AI and more
Digital & Marketing Prioritize tactics and tools to create powerful connections with customers through digital innovation
Medical Affairs Win back the trust of patients, payers and providers with a new lifecycle strategy that puts stakeholder value first
Digital Clinical Trials It’s time for new types of trial: democratized, patient-preferred, siteless and virtual
Market Access Create your value story for the next generation of pharma innovation and ensure patient access to life-changing care.
Hear from critical healthcare stakeholders
No other event brings together thousands of pharma decision-makers alongside key healthcare stakeholders – meet health systems, payers, regulatory bodies, patient associations and healthcare innovations, all with one thing on their mind.
Break-down functional barriers
The most cross-functional pharma event in North America – executives from marketing, commercial, sales, market access, medical affairs, patient engagement, RWE, IT, clinical and more will be attendance – helping you to forge new collaborations and partnerships.
8 tracks: Focus on what matters
Philadelphia is huge. Yet it’s also intimate, tailored to your day-to-day learning needs. You’ll be able to pick from across 8 streams, each focused on a critical topic - including digital marketing, commercial excellence, medical affairs, patient engagement, RWE, market access and clinical innovation.
You won’t find a better place to meet your peers, who have the same challenges as you, since over 69% of the pharma attendees are director-level or above.
Patient-led on principle
At eyeforpharma, we practice what we preach. The eyeforpharma Philadelphia agenda was developed with patients, will be delivered with patients, and will be held accountable by patients at the event itself.
Networking is key
Don’t think you’ll be stuck in a dark conference room for two days. There are hours of onsite and offsite networking sessions, with the 1200+ attendees, plus a variety of interactive thought-leadership sessions away from the stages.
Aurelie Rameau Salamander, Marketing Retail GX HeadComplete, concrete and innovative
Diamond, Gold & Silver passes only
Free to biopharma
Free to biopharma
1200+ networkers Everyone in commercial pharma
1 conference app Connecting you with fellow attendees
Total interaction Roundtables, workshops and break-out sessions.
Other events say they attract senior executives - people with clout, budget, ideas and a mission. We really mean it. 1200 of them.
eyeforpharma Philadelphia attracts a global audience: a variety of job titles, geographies, cultures and opinions create a rich tapestry.
It’s not just about conference sessions. eyeforpharma Philadelphia is also home to a 80+ booth exhibition hall – packed with solutions to market access, commercial, digital, medical and clinical development challenges.
With the eyeforpharma Meeting & Messaging service, as a sponsor or exhibitor, you’ll be able to set up meetings with prospects and ensure your time onsite is as valuable as possible. Over 400 meetings were set up in 2019!
Join one of the 30+ discussions taking place on topics including digital marketing, commercial excellence, patient-centricity, market access, RWE and medical affairs.
Hear from healthcare innovators on the new technologies, ideas and science that is set to disrupt the very nature of healthcare and biopharma.
Grab a coffee and a pastry and recharge your batteries, and your phones!
Find out how digital clinical trials are disrupting clinical development and creating truly patient-centric trials.
Get in touch with the eyeforpharma team
Paul Simms Chairman
Blair Gottscho VP Operations
Izzy Gladstone VP Marketing
Karla Sharp Head of North America
Hannah Brady International Project Director
Saskia Burbach International Project Director
Liz Swift Head of Partnerships
Ed Harris Director, Business Development
Joseph Hargreaves Director, Business Development
Alex Norman Director, Business Development - Clinical